Metro Aerospace

Almaden Genomics Chief Scientific Officer Mark Kunitomi (left) and Almaden's Executive Chairperson Tricia D’Cruz [Photos: Almaden Genomics]

Catalyze Dallas Launches New Portfolio Company to ‘Democratize and Accelerate Bioinformatics’

by | Oct 25, 2022
The Dallas-based venture development firm—which specializes in the commercialization of technology it acquires from Fortune 100 companies—has launched Almaden Genomics, a company with a newly released platform designed to streamline genomic workflows. Formerly part of IBM Research before its acquisition by Catalyze Dallas, Almaden calls its g.nome platform "a revolutionary approach to bioinformatics." “The possibilities for the healthcare innovation it can power are as vast as they are life-changing," says Mark Kunitomi, Almaden's chief scientific officer.
MORE►
Follow the Money: Recuro Health Expands with New Acquisition, Texas Cybersecurity Transplant Raises $70M, and More
by | Aug 22, 2022
Plus, bidding war looms for Dallas-based Signify Health; Fort Worth-based Harvest Returns raises $780K for new fund; Dallas property consulting firm Masterplan is acquired by New York company; Washington D.C. PE firm adds to its Fort Worth architectural platform; Pharos Capital sells stake in diagnostic testing company; and more North Texas deals.
MORE►
A Special Thank you to our sponsors

A collaboration of the Dallas Regional Chamber and Dallas Next, Dallas Innovates is an online news platform covering what's new + next in Dallas - Fort Worth innovation.

© Copyright 2025 | All rights reserved.

Business

Creative

Education

Impact

Invention

Startup

Our Sponsors

Our Partners

Protecting your privacy. We have strengthened our Privacy Policy to better protect you. This Policy includes our use of cookies to give you the best online experience and provide functionality essential to our services. By clicking ‘I Accept’ or by continuing to use our website, you are consenting to our Privacy Policy.